Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Revenue

Checkpoint Therapeutics had revenue of $68.00K in the twelve months ending March 31, 2024, down -61.14% year-over-year. In the year 2023, Checkpoint Therapeutics had annual revenue of $103.00K, a decrease of -46.35%.

• Revenue (ttm): $68.00K
• Revenue Growth: -61.14%
• P/S Ratio: 1,132.35
• Revenue / Employee: $2,957
• Employees: 23
• Market Cap: 77.00M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	103.00K	-89.00K	-46.35%
Dec 31, 2022	192.00K	-76.00K	-28.36%
Dec 31, 2021	268.00K	-801.00K	-74.93%
Dec 31, 2020	1.07M	-639.00K	-37.41%
Dec 31, 2019	1.71M	-1.80M	-51.28%
Dec 31, 2018	3.51M	1.78M	103.25%
Dec 31, 2017	1.73M	-845.00K	-32.88%
Dec 31, 2016	2.57M	1.98M	335.59%
Dec 31, 2015	590.00K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.